盐酸美格鲁特
Miglustat Hydrochloride (N-Butyldeoxynojirimycin Hydrochloride; NB-DNJ hydrochloride; OGT918 hydrochloride)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Miglustat Hydrochloride (N-Butyldeoxynojirimycin Hydrochloride; NB-DNJ hydrochloride; OGT918 hydrochloride)
CAS210110-90-0
FormulaC10H21NO4.HCl
MW255.74
Appearance White to light brown
Storage condition Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years).
Security information
Product details

 Miglustat, also known as OGT 918 and NB-DNJ, is a drug developed by Actelion and is used primarily to treat Type I Gaucher disease (GD1). Miglustat inhibits glucosylceramide synthase, an essential enzyme for the synthesis of most glycosphingolipids (it forms glucosylceramide and accumulates within the macrophages).

Related literature
Related
Sorry, no related items
History
Miglustat Hydrochloride (N-Butyldeoxynojirimycin Hydrochloride; NB-DNJ hydrochloride; OGT918 hydrochloride)
Oleandomycin
Amyloid β-Peptide (1-42),human; β-Amyloid (1-42),human
Lixisenatide
Ketanserin tartrate | R41468 tartrate
CX-5461 dihydrochloride
Dinoprost Tromethamine Salt | Dinoprost Trometamol | Prostaglandin F2a tromethamine salt | PGF2α THAM | Prostaglandin F2α THAM